4.4 Article

The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19

Journal

CURRENT OPINION IN PHARMACOLOGY
Volume 43, Issue -, Pages 93-98

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2018.08.005

Keywords

-

Funding

  1. Italian Association for Cancer Research (AIRC) [IG 18987]
  2. NR-NET FP7 Marie Curie ITN
  3. Italian Ministry of Health [GR-2010-2314703]

Ask authors/readers for more resources

Elevated bile acid (BA) concentrations in the liver is associated with severe disease, including cholestasis and hepatocellular carcinoma. The nuclear Farnesoid X Receptor (FXR) is the master regulator of BAs homeostasis. In the ileum, BA-dependent FXR activation induces the production of the fibroblast growth factor FGF19, a hormone that reaches the liver through the portal system where it represses the expression of CYP7A1, the rate limiting enzyme in the process of hepatic BAs synthesis. This gut-liver FXR-FGF19 dual action is the paradigm of physiological BA regulation and it is currently targeted in the clinical practice for liver disease such as primary cholangitis. At a variance of FXR activation, native FGF19 has strong anti-cholestatic and anti-fibrotic activity in the liver but it retains peculiar pro-tumorigenic actions. Thus, novel analogues have been generated to avoid tumorigenic capacity while maintaining BA metabolic action. Here we present a novel and intriguing view on the putative possibility to target the FXR-FGF19 duo in order to offer a bona fide promising therapeutic approach to bile acid promoted hepatocarcinoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Another One Bites the Gut: Nuclear Receptor LRH-1 in Intestinal Regeneration and Cancer

Roberta Zerlotin, Maria Arconzo, Elena Piccinin, Antonio Moschetta

Summary: LRH-1, a nuclear receptor highly expressed in stem cells of the crypts, plays a key role in regulating intestinal epithelium and is associated with colorectal cancer.

CANCERS (2021)

Review Gastroenterology & Hepatology

Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH

Marica Cariello, Elena Piccinin, Antonio Moschetta

Summary: Nonalcoholic fatty liver disease encompasses a spectrum of liver injuries, from simple steatosis to steatohepatitis and cirrhosis. Nonalcoholic steatohepatitis (NASH) is characterized by liver steatosis, inflammation, hepatocyte damage, and fibrosis. Genetic predisposition and environmental factors such as dietary habits and obesity may contribute to the progression of NASH. The role of lipid-sensing nuclear receptors in the pathogenesis and treatment of NASH, including peroxisome proliferator-activated receptors, farnesoid X receptor, and liver X receptors, is discussed in this study.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Lipid metabolism in colon cancer: Role of Liver X Receptor (LXR) and Stearoyl-CoA Desaturase 1 (SCD1)

Elena Piccinin, Marica Cariello, Antonio Moschetta

Summary: Colorectal cancer is a common cancer worldwide, with cellular metabolism reprogramming recognized as a key step in carcinogenesis. Aberrant activation of lipid metabolism in intestinal tumor cells leads to increased lipid uptake or endogenous synthesis to support proliferation. Strategies to limit lipid accumulation are being developed, with a focus on two major players - Liver X Receptor and Stearoyl-CoA Desaturase 1 - in lipid metabolism contributing to CRC development. Further investigations are needed to develop specific therapies targeting intestinal cancer cell proliferation and CRC progression.

MOLECULAR ASPECTS OF MEDICINE (2021)

Article Biochemistry & Molecular Biology

Intracoronary monocyte expression pattern and HDL subfractions after non-ST elevation myocardial infarction

Marica Cariello, Roberto Salvia, Jennifer Hardfeldt, Marilidia Piglionica, David Rutigliano, Pasquale Caldarola, Alice Ossoli, Michele Vacca, Giusi Graziano, Stefano Battaglia, Roberta Zerlotin, Maria Arconzo, Lucilla Crudele, Carlo Sabba, Laura Calabresi, Antonio Moschetta

Summary: The study observed differences in cholesterol acceptability and efflux capacity in serum and monocytes of NSTEMI patients, indicating potential mechanisms for post-infarction treatment. The activation of LXR-driven cholesterol efflux capacity in intracoronary monocytes post-infarction may help overcome reduced serum cholesterol acceptance and inhibit local inflammation.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Review Gastroenterology & Hepatology

Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver

Raffaella Maria Gadaleta, Antonio Moschetta

Summary: FGFR4 and its ligand FGF19 play crucial roles in cellular processes, including the development of liver tumors. FGFR4 inhibitors are a promising treatment option for HCC, while using FGF19 analogues to activate FGFR4-KLOTHO represents a novel therapeutic strategy for other liver diseases.

JOURNAL OF HEPATOLOGY (2021)

Article Oncology

Adhesion of Platelets to Colon Cancer Cells Is Necessary to Promote Tumor Development in Xenograft, Genetic and Inflammation Models

Marica Cariello, Elena Piccinin, Roberta Zerlotin, Marilidia Piglionica, Claudia Peres, Chiara Divella, Anna Signorile, Gaetano Villani, Giuseppe Ingravallo, Carlo Sabba, Antonio Moschetta

Summary: Platelets play a crucial role in inflammation and tumor development through direct interactions with other cell types, especially through their association with P-selectin. Removing P-selectin from platelets has been shown to reduce tumor growth and inhibit colon cancer progression. This suggests that inhibiting platelets' adhesion to tumor cells could be a novel therapeutic approach for treating colon cancer.

CANCERS (2021)

Article Nutrition & Dietetics

Monocyte-to-HDL Ratio (MHR) Predicts Vitamin D Deficiency in Healthy and Metabolic Women: A Cross-Sectional Study in 1048 Subjects

Carlo De Matteis, Lucilla Crudele, Marica Cariello, Stefano Battaglia, Giuseppina Piazzolla, Patrizia Suppressa, Carlo Sabba, Elena Piccinin, Antonio Moschetta

Summary: This study investigated the association between vitamin D levels and inflammatory status in a population of adults. The results showed an inverse relationship between vitamin D levels and the monocytes-to-high density lipoprotein ratio (MHR). When stratified by gender and body composition, men showed a significant relationship only in cases of central obesity, while women exhibited a lifelong negative correlation between circulating vitamin D levels and MHR, regardless of metabolic status.

NUTRIENTS (2022)

Article Biochemistry & Molecular Biology

Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome

Gabriele Mocciaro, Simona D'Amore, Benjamin Jenkins, Richard Kay, Antonio Murgia, Luis Vicente Herrera-Marcos, Stefanie Neun, Alice P. Sowton, Zoe Hall, Susana Alejandra Palma-Duran, Giuseppe Palasciano, Frank Reimann, Andrew Murray, Patrizia Suppressa, Carlo Sabba, Antonio Moschetta, Albert Koulman, Julian L. Griffin, Michele Vacca

Summary: Metabolic syndrome (MetS) is characterized by cardiovascular risk factors such as central obesity and atherogenic dyslipidemia. This study used an integrated omics approach to study lipoprotein remodeling and HDL composition in subjects with MetS. The results showed abnormal lipid levels and impaired phospholipid metabolism in HDL, which may be related to the decreased activity of lecithin cholesterol acyltransferase (LCAT).

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Nutrition & Dietetics

Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the Bile Acid Code

Raffaella Maria Gadaleta, Marica Cariello, Lucilla Crudele, Antonio Moschetta

Summary: Bile acid species and gut microbiota are crucial for intestinal mucosa homeostasis, shaping and affecting each other. High levels of secondary bile acids are detrimental, and a lack of BSH-active bacteria can lead to intestinal inflammation.

NUTRIENTS (2022)

Article Oncology

Intestinal FXR Activation via Transgenic Chimera or Chemical Agonism Prevents Colitis-Associated and Genetically-Induced Colon Cancer

Marica Cariello, Roberta Zerlotin, Emanuela Pasculli, Elena Piccinin, Claudia Peres, Emanuele Porru, Aldo Roda, Raffaella Maria Gadaleta, Antonio Moschetta

Summary: The activation of intestinal FXR can prevent both inflammation- and genetically-driven colorectal tumorigenesis by modulating the size and composition of bile acid pool, providing new possibilities for the therapeutic management of intestinal inflammation and tumorigenesis.

CANCERS (2022)

Article Medicine, General & Internal

Liver Fibrosis Indices Predict the Severity of SARS-CoV-2 Infection

Lucilla Crudele, Fabio Novielli, Stefano Petruzzelli, Stefano Battaglia, Antonio Francesco Maria Giuliano, Rosa Melodia, Chiara Maria Morano, Paola Dell'Aquila, Renata Moretti, Luigi Castorani, Roberto Salvia, Gianfranco Inglese, Nicola Susca, Lucrezia Dell'Olio, Francesca Falcone, Mariapaola Castaldo, Carlo De Matteis, Carlo Sabba, Antonio Moschetta

Summary: This study aimed to determine if parameters assessing metabolic status can predict prognosis and mortality risk in COVID-19 patients. The results showed that liver fibrosis scores have strong predictive power for in-hospital mortality, length of hospitalization, and admission to ICU.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Nutrition & Dietetics

Identification of a Novel Score for Adherence to the Mediterranean Diet That Is Inversely Associated with Visceral Adiposity and Cardiovascular Risk: The Chrono Med Diet Score (CMDS)

Carlo De Matteis, Lucilla Crudele, Stefano Battaglia, Tiziana Loconte, Arianna Rotondo, Roberta Ferrulli, Raffaella Maria Gadaleta, Giuseppina Piazzolla, Patrizia Suppressa, Carlo Sabba, Marica Cariello, Antonio Moschetta

Summary: Adherence to the Mediterranean diet is associated with reduced mortality, particularly in individuals with cardiovascular disease, obesity, and diabetes. Existing validated Mediterranean diet scores did not show a significant association with adiposity, leading to the proposal of a new questionnaire, the Chrono Med-Diet score (CMDS), which focuses on dietary chronobiology and physical activity. CMDS was found to be linked to increased waist circumference, dysmetabolic conditions, cardiovascular risk, and Fatty Liver Index.

NUTRIENTS (2023)

Article Infectious Diseases

Impact of a Pro-Active Infectious Disease Consultation on the Management of a Multidrug-Resistant Organisms Outbreak in a COVID-19 Hospital: A Three-Months Quasi-Experimental Study

Davide Fiore Bavaro, Nicolo De Gennaro, Alessandra Belati, Lucia Diella, Roberta Papagni, Luisa Frallonardo, Michele Camporeale, Giacomo Guido, Carmen Pellegrino, Maricla Marrone, Alessandro Dell'Erba, Loreto Gesualdo, Nicola Brienza, Salvatore Grasso, Giuseppe Columbo, Antonio Moschetta, Giovanna Elisiana Carpagnano, Antonio Daleno, Anna Maria Minicucci, Giovanni Migliore, Annalisa Saracino

Summary: The introduction of a pro-active Infectious Disease (ID) consultation in a COVID-19 hospital can reduce the mortality risk of patients with MDROs infections by optimizing treatment and diagnostic strategies to improve patient outcomes.

ANTIBIOTICS-BASEL (2023)

Letter Gastroenterology & Hepatology

Reply to: Reconsidering low HDL-cholesterol levels as a predictive factor for the development of hepatocellular carcinoma

Lucilla Crudele, Carlo De Matteis, Antonio Moschetta

JHEP REPORTS (2023)

Review Medicine, General & Internal

Gut microbiota in the pathogenesis and therapeutic approaches of diabetes

Lucilla Crudele, Raffaella Maria Gadaleta, Marica Cariello, Antonio Moschetta

Summary: The gut-liver axis plays a significant role in the development and treatment of diabetes, and the gut microbiota is a key factor. There are ongoing studies evaluating the therapeutic efficacy of probiotics in diabetes and its complications.

EBIOMEDICINE (2023)

No Data Available